Generating CRISPR-Cas9-Mediated Null Mutations and Screening Targeting Efficiency in Human Pluripotent Stem Cells

Area of Science:

• Stem cell biology
• Genome editing technologies
• Developmental biology

Background:

• Human pluripotent stem cells (hPSCs) are valuable models for studying human development and disease.
• CRISPR-Cas9 technology offers precise gene editing capabilities.
• Investigating gene function in hPSCs is essential for understanding cell fate and disease mechanisms.

Purpose of the Study:

• To provide an optimized protocol for efficient CRISPR-Cas9 genome editing in hPSCs.
• To enable the generation of null mutations for functional gene studies.
• To detail methods for assessing editing efficiency and genomic integrity.

Main Methods:

• CRISPR-Cas9 system implementation in hPSCs.
• Screening of single guide RNAs (sgRNAs) for high targeting efficiency.
• Nucleofection of primed hPSCs.
• Analysis of on-target mutations (indels) using MiSeq.
• Generation of clonally derived null mutant hPSC lines.
• Karyotyping to evaluate chromosomal stability.

Main Results:

• An optimized protocol for CRISPR-Cas9 mediated gene editing in hPSCs was established.
• Methods for screening sgRNAs and validating their efficiency were detailed.
• Techniques for generating and characterizing null mutant hPSC lines were presented.
• Assessment of on-target mutation spectrum and karyotypic stability was performed.

Conclusions:

• The developed protocol facilitates efficient CRISPR-Cas9 genome editing in hPSCs for functional gene analysis.
• This method is critical for advancing research in human development and regenerative medicine.
• The protocol emphasizes quality control for generating reliable null mutant hPSC lines.